ADTX

ADiTx Therapeutics Inc.

Price

$0.42

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ADTX price

ADiTx Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ADTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ADTX

Valuation

P/E

0.00

Sector -4.15

Industry -4.15

P/BV

0.00

Sector 2.06

Industry 2.06

P/Revenue (PSR)

0.00

Sector -4.16

Industry -4.16

EV/EBITDA

0.02

Sector -241.86

Industry -241.86

EV/EBIT

0.02

Sector -671.75

Industry -671.75

P/EBITDA

0.00

Sector -4.30

Industry -4.30

P/EBIT

0.00

Sector -4.35

Industry -4.35

P/Total Assets

0.00

Sector 1.46

Industry 1.46

P/Net Current Assets

0.00

Sector -12.67

Industry -12.67

P/Working Capital

0.00

Sector -12.58

Industry -12.58

EPS

-999,999.99

Sector -2.19

Industry -2.19

BVPS

-999,999.99

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

0.00%

Sector 36.44%

Industry 36.44%

EBITDA Margin

-160,900.00%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

-161,400.00%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

-100.00%

Sector -38.78%

Industry -38.78%

Net Profit Margins

-100.00%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

147.74%

Sector -67.01%

Industry -67.01%

ROA

-373.54%

Sector -66.28%

Industry -66.28%

ROIC

-97.74%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.06

Sector 2.90

Industry 2.90

Net Debt / EBITDA

0.02

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

0.02

Sector -3.79

Industry -3.79

Net Debt / Equity

0.01

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

0.00

Sector 0.00

Industry 0.00

Equity/Assets

-2.53

Sector 0.42

Industry 0.42

Liabilities/Assets

3.53

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-36.90%

Sector -

Industry -

5Y Earnings CAGR

2.30%

Sector -

Industry -

Fundamentals ADTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ADTX ADiTx Therapeutics Inc.	$0.42	-99.98%	0.00%	0.00	0.00	147.74%	-100.00%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ADTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ADiTx Therapeutics

ADiTx Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

9 years

Founded: 2017

2020

Time since IPO - 6 years

6

Employees

ADiTx Therapeutics Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-35.17 million.

The company employs approximately 6 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, ADiTx Therapeutics Inc. reported $10.00 Thousand in revenue, generating net income of $-51.96 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ADTX.

Market cap

Net worth

$-35.17 million

$-35,170,000.00

Assets

$13.91 million

$13,910,000.00

Total Shares Outstanding

1.00

000

Average Daily Trading Volume

$219.34 million

$219,336,789.01

Sector

Healthcare

Industry

Biotecnologia

ADTX

ADTX revenue and profits

Financial Results ADTX

DRAG THE FRAME TO SEE MORE DATA

ADTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14